The Department of Cardiology was one of the first core departments founded in 1994 at SRRSH. It has been developed into an integrated professional team, providing medical care service, teaching and training and conducting scientific research, under the leadership of Prof. FU Guosheng.

Based in Zhejiang province, the department has been reputed to be one of the best for cardiac disease treatment over the past 20 years, and is also renowned as one of the most important cardiovascular intervention training base in China.

At present, there are 93 doctors, including 37 with senior professional titles and 6 doctoral supervisors in the department, and six sub-specialties have been set up, including chest pain group, structural heart disease group, cardiovascular imaging group, electrical physiological and pacing group, heart failure group, cardiomyopathy group, sudden cardiac death prevention group, and clinical trial group. The department has more than 160 beds on Qingchun Campus and more than 90 beds on Qiantang Campus. Both Grand Canal Campus and Shaoxing Campus have opened outpatient clinics and inpatient wards. The department has 24 cardiac catheter labs. Its annual interventional procedures volume has been at the forefront of Zhejiang province for many years.

Medical Care Service

1.Diagnosis and treatment of coronary heart disease by percutaneous coronary intervention;

2.Diagnosis and treatment of arrhythmia by radio frequency ablation and pacemaker implantation;

3.Diagnosis and treatment of valvular heart disease by percutaneous intervention;

4.Diagnosis and treatment of congenital heart disease by percutaneous canopy closure;

5.Cardiomyopathy diagnosis and treatment.

The department keeps a close relationship with Oklahoma University Heart Rhythm Center, Loma Linda University Medical Center and Kiel University Hospital. The department sends two members at least overseas as visiting scholar each year.

1.Certified national interventional training base, qualified for coronary heart disease, arrhythmia as well as structural heart disease interventional therapy training

2. Zhejiang Key Laboratory of Cardiovascular Intervention and Precision Medicine, Hangzhou, China

3. Engineering Research Center for Cardiovascular Innovative Devices of Zhejiang Province, Hangzhou, China

4.Organizer of the XIZI Joint International Cardiovascular Conference (XIZI-JICC)

The department has been rewarded with a number of grants from both the National Natural Science Foundation and the the Natural Science Foundation of Zhejiang Province over the past 20 years. More than eighty academic papers have been published in the world-class journals including Circulation, Circulation Research, JACC , Hypertension, etc.

Research Directions

1.Research and development of innovative cardiovascular interventional devices, such as absorbable stents, drug-coated balloons, etc.

2.Clinical and innovative research on interventional therapy for complex coronary heart disease and arrhythmia.

3.Basic and clinical research on coronary heart disease, atrial fibrillation, hypertrophic heart disease, myocardial amyloidosis disease, etc.